1.Research advances in prognostic score models and biomarkers for acute-on-chronic liver failure
Xinyi XU ; Xia YU ; Huilan TU ; Xiaohan QIAN ; Yida YANG ; Yu SHI
Journal of Clinical Hepatology 2025;41(6):1030-1036
Acute-on-chronic liver failure (ACLF) is a complex clinical syndrome, and early identification and accurate prognostic evaluation are of great importance for patient treatment and management. In recent years, with in-depth research on the pathogenesis of ACLF, multiple prognostic biomarkers have been proposed and used in clinical practice. This article systematically reviews the research advances in prognostic biomarkers for ACLF from the aspects of clinical predictive models, immunological biomarkers, metabolic biomarkers, genetic and epigenetic biomarkers, microbiome-related biomarkers, and emerging technologies such as artificial intelligence and multi-omics, and it also discusses the value and application prospects of these biomarkers in the prognostic evaluation of ACLF and proposes future research directions, in order to provide a scientific and comprehensive reference for clinicians, guide individualized treatment and management of ACLF patients, and finally improve the clinical outcomes of patients.
2.Surgical Perspective on Lung Cancer in 2024: Innovation and Challenges.
Pengxu KONG ; Xiaohan CHEN ; Wang LV ; Pinghui XIA ; Luming WANG ; Jian HU
Chinese Journal of Lung Cancer 2025;28(3):195-200
Lung cancer, a highly prevalent and deadly malignancy globally, poses a significant disease burden in China and is the leading cause of cancer death. Despite rapid advances in medicine, its incidence and mortality rates remain stubbornly high, making it a major challenge in public health. Against the backdrop of rapid progress in precision medicine, the paradigm of lung cancer treatment is shifting from single traditional therapy to multi-dimensional integration. This article comprehensively reviews the innovations and challenges in lung cancer surgery in 2024, aiming to explore the future development of surgical treatment with colleagues and to improve patients' quality of life and achieve the goal of "cure".
.
Humans
;
Lung Neoplasms/surgery*
3.Academic Thoughts of Famous Diannan Bone-Setting Physician SU Caichen and His Specific Bone-Setting Manipulations
Miao TIAN ; Youyang ZHU ; Yubo XIA ; Xiaohan ZHOU ; Wen LUO ; Ying GUO ; Tao WANG
Journal of Guangzhou University of Traditional Chinese Medicine 2025;42(1):225-230
Diannan Su's bone-setting school is one of the orthopedic schools of traditional Chinese medicine(TCM),and Su Caichen,a famous bone-setting physician in Diannan,is the key figure of Diannan Su's bone-setting school.This paper systematically summarized Su Caichen's bone-setting academic thoughts of"adaptation","harmonization"and"recovery",presented his core bone-setting concepts of"original traumatic chamber","bone-setting prior to activating blood and vessles,bone-setting together with soothing tendons and then fracture healing naturally after the removal of stasis",and introduced his five kinds of bone-setting manipulations for treating the common upper limb fractures in detail,namely shaking and pushing manipulations for distal radius fracture,floating manipulations for fracture of both ulna and radius,five-step manipulations for supracondylar fractures of humerus,staging manipulations for humeral shaft fracture,and degloving manipulations for proximal humeral fractures complicated with shoulder dislocation.Su Caichen's bone-setting academic thoughts,bone-setting concepts and his specific TCM bone-setting manipulations have constructed the academic and theoretical system of Diannan Su's bone-setting school,which will provide an approach for TCM treatment of orthopedic diseases,and will promote the inheritance and development of the specific TCM orthopedic schools.
4.Immune-microbiota crosstalk in HBV infection: diagnostic and therapeutic implications across disease stages
Huilan TU ; Xia YU ; Xinyi XU ; Longxian LYU ; Xiaohan QIAN ; Yu SHI ; Yida YANG
Chinese Journal of Clinical Infectious Diseases 2025;18(4):307-313
Hepatitis B virus(HBV)infection poses a significant global health burden,with chronic infection driving progression to cirrhosis,hepatic failure,and hepatocellular carcinoma(HCC). Mounting evidence implicates immune dysfunction and microbiota dysbiosis as core drivers of disease progression across all HBV infection stages. Gut and tissue-specific microbiota alterations disrupt innate/adaptive immunity,fueling inflammation,immunosuppression,and tumor immune evasion in chronic and end-stage disease. This review synthesizes mechanisms of immune-microbiota interplay in HBV pathogenesis and explores their translational potential for diagnostics and targeted interventions,including microbiota modulation and microbial biomarker applications.
5.Clinical characteristics and risk factors in patients with upper urinary tract stones complicated with non-alcoholic fatty liver disease
Enxu XIE ; Xuelian GU ; Xiaohan CHU ; Shengwei ZHANG ; Xinze XIA ; Xiaofu WANG ; Changwei LIU ; Changbao XU
Journal of Modern Urology 2025;30(7):571-575
Objective To explore the clinical characteristics and risk factors of upper urinary tract stones complicated with non-alcoholic fatty liver disease(NAFLD),so as to provide reference for the prevention of this disease.Methods The clinical data of 158 NAFLD patients undergoing surgical treatment in our hospital during Jan.2022 and Jul.2023 were retrospectively analyzed.According to whether the patients were complicated with NAFLD,they were divided into the NAFLD group(n=56)and non-NAFLD group(n=102).The general data,laboratory indexes and 24-h urinary metabolic indexes were compared between the two groups,and the risk factors were analyzed with univariate and multivariate logistic regression analyses.Results Compared with the non NAFLD group,the NAFLD group had higher BMI[(28.17±4.17)vs.(24.11±3.72),P<0.001],blood uric acid[(354.13±111.01)μmol/L vs.(294.41±93.72)μmol/L,P<0.001],and 24-h urinary oxalate level[(37.74±15.00)mmol vs.(27.73±15.27)mmol,P<0.001].Multivariate logistic analysis showed that BMI(OR=1.311,P<0.001),24-h urinary oxalate(OR=1.046,P=0.004),and 24-h urinary magnesium(OR=0.599,P=0.002)were the independent factors for NAFLD with upper urinary tract stones.Conclusion NAFLD complicated with upper urinary tract stones is significantly associated with high BMI,high 24-h urinary oxalate,and low 24-h urinary magnesium.
6.Clinical characteristics and risk factors in patients with upper urinary tract stones complicated with non-alcoholic fatty liver disease
Enxu XIE ; Xuelian GU ; Xiaohan CHU ; Shengwei ZHANG ; Xinze XIA ; Xiaofu WANG ; Changwei LIU ; Changbao XU
Journal of Modern Urology 2025;30(7):571-575
Objective To explore the clinical characteristics and risk factors of upper urinary tract stones complicated with non-alcoholic fatty liver disease(NAFLD),so as to provide reference for the prevention of this disease.Methods The clinical data of 158 NAFLD patients undergoing surgical treatment in our hospital during Jan.2022 and Jul.2023 were retrospectively analyzed.According to whether the patients were complicated with NAFLD,they were divided into the NAFLD group(n=56)and non-NAFLD group(n=102).The general data,laboratory indexes and 24-h urinary metabolic indexes were compared between the two groups,and the risk factors were analyzed with univariate and multivariate logistic regression analyses.Results Compared with the non NAFLD group,the NAFLD group had higher BMI[(28.17±4.17)vs.(24.11±3.72),P<0.001],blood uric acid[(354.13±111.01)μmol/L vs.(294.41±93.72)μmol/L,P<0.001],and 24-h urinary oxalate level[(37.74±15.00)mmol vs.(27.73±15.27)mmol,P<0.001].Multivariate logistic analysis showed that BMI(OR=1.311,P<0.001),24-h urinary oxalate(OR=1.046,P=0.004),and 24-h urinary magnesium(OR=0.599,P=0.002)were the independent factors for NAFLD with upper urinary tract stones.Conclusion NAFLD complicated with upper urinary tract stones is significantly associated with high BMI,high 24-h urinary oxalate,and low 24-h urinary magnesium.
7.Immune-microbiota crosstalk in HBV infection: diagnostic and therapeutic implications across disease stages
Huilan TU ; Xia YU ; Xinyi XU ; Longxian LYU ; Xiaohan QIAN ; Yu SHI ; Yida YANG
Chinese Journal of Clinical Infectious Diseases 2025;18(4):307-313
Hepatitis B virus(HBV)infection poses a significant global health burden,with chronic infection driving progression to cirrhosis,hepatic failure,and hepatocellular carcinoma(HCC). Mounting evidence implicates immune dysfunction and microbiota dysbiosis as core drivers of disease progression across all HBV infection stages. Gut and tissue-specific microbiota alterations disrupt innate/adaptive immunity,fueling inflammation,immunosuppression,and tumor immune evasion in chronic and end-stage disease. This review synthesizes mechanisms of immune-microbiota interplay in HBV pathogenesis and explores their translational potential for diagnostics and targeted interventions,including microbiota modulation and microbial biomarker applications.
8.Effects of Guben Fangxiao Beverage (固本防哮饮) on Lung Tissue Oxidative Stress and AMPK/Nrf2/HO-1 Pathway in Mice with Bronchial Asthma in Remission
Xiaohan DAI ; Xia ZHAO ; Hua YAN ; Yiwen SHAN
Journal of Traditional Chinese Medicine 2024;65(2):205-212
ObjectiveTo investigate the possible mechanism of Guben Fangxiao Beverage (固本防哮饮) for the prevention and treatment of chronic airway inflammation during asthma remission. MethodsThirty-six female Balb/c mice were randomly divided into normal group, model group, low-, medium-, and high-dose of Guben Fangxiao Beverage group and montelukast sodium group, with 6 mice in each group. Except for the normal group, ovalbumin and respiratory syncytial virus were used in other groups to establish a mouse model of bronchial asthma in remission stage. After molding, the low-, medium-, and high-dose groups of Guben Fangxiao Beverage were respectively given 12, 24, and 36 g/(kg·d), the montelukast sodium group was given montelukast sodium granule 2.6 mg/(kg·d), and the mice in the normal group and model group were given 20 ml of double-distilled water, all by gavage, once a day for 28 days. The levels of interleukin 4 (IL-4) and interleukin 5 (IL-5) in the lung tissue of mice were detected; HE staining was used to observe the pathology of the lung tissue and to score the inflammation; DHE staining was used to observe the level of reactive oxygen species (ROS) in the lung tissue, and the activities of mitochondrial respiratory chain complexes Ⅰ, Ⅱ, Ⅲ, Ⅳ, and Ⅴ in the lung tissue were detected; the levels of serum superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA) and adenosine triphosphate (ATP) were detected; the protein expression levels of phosphorylated adenosine monophosphate-activated protein kinase (p-AMPK), nuclear factor erythroid 2-related factor 2 (Nrf2), haem oxygenase 1 (HO-1) and cAMP responsive element binding protein (CREB) in the lung tissues of the model group were detected by Western blot. ResultsCompared with the normal group, the histopathological results of the lungs of mice in the model group showed an increase in inflammatory cells around the airways and an increase in inflammatory score; DHE staining showed an increase in the level of ROS, and an increase in the levels of IL-4 and IL-5 in the lung tissues; the levels of serum SOD, CAT, and ATP were reduced, and the level of MDA was elevated; the activities of the mitochondrial respiratory chain complexes Ⅰ, Ⅱ, Ⅲ, Ⅳ, and Ⅴ of the lung tissues were reduced, and the activities of p-AMPK, Nrf2, CREB protein expression decreased (P<0.05). Compared with the model group, the lung tissue inflammatory cells and inflammation scores of mice in each Guben Fangxiao Beverage dose group and montelukast sodium group were reduced; the levels of ROS, IL-4 and IL-5 in the lung tissue were reduced; the levels of CAT and ATP in the serum increased, and the content of MDA was reduced; and the activities of mitochondrial respiratory chain complexes Ⅰ and Ⅱ, as well as the expression of CREB protein, were elevated in the lung tissue (P<0.05). Compared with the high-dose group, the MDA level of the medium-dose Guben Fangxiao Beverage group decreased (P<0.05). The activity of mitochondrial respiratory chain complex V in the medium-dose group was higher than that in the montelukast sodium group, and the activity of mitochondrial respiratory chain complex Ⅳ in the medium- and high-dose groups was higher than that in the low-dose group (P<0.05). ConclusionGuben Fangxiao Beverage can inhibit oxidative stress and improve mitochondrial function to relieve chronic airway inflammation in bronchial asthma model mice during asthma remission, and its mechanism may be related to the activation of AMPK/Nrf2/HO-1 signaling pathway.
9.Electroacupuncture improves learning and memory function and promotes hippocampal synaptic regeneration in rats with cerebral ischemia-reperfusion injury.
Ruhui LIN ; Jinyan XIA ; Xiaohan MA ; Zuanfang LI
Journal of Southern Medical University 2024;44(12):2317-2326
OBJECTIVES:
To explore the neuroprotective mechanism of electroacupuncture at the acupoints Baihui and Shenting in rats with cerebral ischemia-reperfusion (IR) injury.
METHODS:
Forty-eight male SD rats were equally randomized into sham operation group, cerebral IR model group, acupoint electroacupuncture group and non-acupoint acupuncture group. In the latter 3 groups, cerebral focal ischemic injury was induced using the Longa method; in the two electroacupuncture groups, electroacupuncture was performed either at the acupoints Baihui and Shenting or at non-acupoint sites for 7 days. The changes in neurological deficit scores, cerebral infarction volume, learning and memory function, pathologies in hippocampal CA1 area, neuronal and synaptic ultrastructures, and synaptic density of the rats were observed, and serum GABA level and mRNA and protein expressions of GABAAR α1, CaMK II, SYN1 and PSD-95 in the hippocampal tissue were detected.
RESULTS:
Compared with those in cerebral IR model group, the rats receiving electroacupuncture at the acupoints, but not those with electroacupuncture at the non-acupoints, showed significantly decreased neurological deficit scores and cerebral infarction volume with shortened escape latency and increased platform crossings. Electroacupuncture at the acupoints significantly increased neuronal cell number, decreased the width of the synaptic gaps and increased density of synaptic bodies in the ischemic hippocampal CA1 area, resulting also in increased serum GABA levels and hippocampal expressions of GABAARα1, SYN1 and PSD-95 and lowered expression level of CaMK II.
CONCLUSIONS
Electroacupuncture at Baihui and Shenting improves learning and memory function of rats with cerebral IR injury possibly through a mechanism that promotes synaptic regeneration, upregulates hippocampal expressions of GABAAR α 1, SYN1 and PSD-95 and downregulates the expression of CaMK II.
Animals
;
Electroacupuncture
;
Reperfusion Injury/therapy*
;
Male
;
Rats
;
Rats, Sprague-Dawley
;
Brain Ischemia/therapy*
;
Hippocampus/metabolism*
;
Memory
;
Learning
;
Disks Large Homolog 4 Protein/metabolism*
;
Synapses
;
Acupuncture Points
;
Calcium-Calmodulin-Dependent Protein Kinase Type 2/metabolism*
;
Receptors, GABA-A/metabolism*
;
gamma-Aminobutyric Acid/metabolism*
10.Research progress of bacteria and their derivatives-mediated tumor therapy
Xiaohan YANG ; Feng LYU ; Xia DONG
International Journal of Biomedical Engineering 2024;47(6):523-529
Bacteria and their derivatives-mediated tumor therapy is an emerging therapeutic strategy. This strategy uses bacteria or bacterial derivatives as drug carriers to deliver drugs to tumor tissues through the targeting and motility of bacteria or bacterial derivatives and utilizes their special biological characteristics to cooperate with other therapies. In this review, the mechanism and advantages of bacteria-mediated tumor therapy were summarized, focusing on the combined application of bacterial therapy and chemotherapy, photothermal therapy, and radiotherapy, which improves the therapeutic effect through a synergistic effect. At the same time, the characteristics, structure, and composition of bacterial derivatives of bacterial outer membrane vesicles (OMVs) and minicells and their application in tumor therapy were also summarized. Although there are still some problems to be solved in the treatment of tumors mediated by bacteria and their derivatives, their potential to colonize in tumors and induce immune responses cannot be ignored. This therapy also provides new ideas for tumor therapy.

Result Analysis
Print
Save
E-mail